SCHEMBL9890975

SCHEMBL9890975

Cc1ccc2c(S(=O)(=O)c3ccccc3)cc(-c3cnc(-c4ccccc4)s3)nc2c1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
KDM4E B2RXH2 9/20 0.43
RAB9A P51151 7/20 0.43
NPSR1 Q6W5P4 6/20 0.43
NPC1 O15118 6/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 7/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
LMNA P02545 5/20 0.39
HTT P42858 2/20 0.39
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906969 0.88 KDM4E (0.42) ALDH1A1KDM4ERAB9ANPSR1NPC1
SCHEMBL10015186 0.86 RAB9A (0.38) ALDH1A1KDM4ERAB9ANPSR1NPC1
SCHEMBL9890976 0.82 MAPT (0.35) ALDH1A1KDM4ENPSR1MAPTHPGD
SCHEMBL9890971 0.78 HPGDS (0.38) ALDH1A1KDM4ENPSR1HPGDLMNA
SCHEMBL15428931 0.78 NPY5R (0.38) ALDH1A1KDM4ENPSR1HPGDLMNA
SCHEMBL15428933 0.77 COMT (0.38) ALDH1A1KDM4ENPSR1HPGDLMNA
SCHEMBL9890970 0.76 ALDH1A1 (0.35) ALDH1A1KDM4ENPSR1HPGDLMNA
SCHEMBL15428930 0.76 COMT (0.34) ALDH1A1KDM4ENPSR1MAPTHPGD
SCHEMBL15428932 0.76 ADORA2A (0.36) ALDH1A1KDM4EHTTCYP1A2CYP3A4
SCHEMBL9890972 0.75 HTR6 (0.35) ALDH1A1KDM4EHPGDHTTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633320-B2 Process for preparing bromo-substituted quinolines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-21 US disclosed
US-20120142929-A1 PROCESS FOR PREPARING SULFONYL QUINOLINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142929-A1 PROCESS FOR PREPARING SULFONYL QUINOLINES GYS2, CYP3A7, GBA1 ALDH1A1 771/4885KDM4E 2420/4885RAB9A 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.